Expansion of tumor-T cell pairs from fine needle aspirates of melanoma metastases

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 495-504

  Panelli, Monica C ^a   Riker, Adam ^a   Kammula, Udai ^a   Wang, Ena ^a   Lee, Kang Hun ^b   Rosenberg, Steven A ^a   Marincola, Francesco M ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MELANOMA ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; ASPIRATION BIOPSY; CANCER CELL; CANCER CELL CULTURE; CANCER IMMUNOLOGY; CANCER REGRESSION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0033985781     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.495     Document Type: Article

References (48)

1. Rosenberg, S. A. 1997. Cancer vaccines based on the identification of genes encoding cancer regression antigens, Immunol. Today 18:175.
2. Boon, T., P. G. Coulie, and B. Van den Eynde. 1997. Tumor antigens recognized by T cells, Immunol. Today 18:267.
3. Rivoltini, L., Y. Kawakami, K. Sakaguchi, S. Southwood, A. Seite, P. F. Robbins, F. M. Marincola, M. Salgaller, J. R. Yannelli, E. Appella, and S. A. Rosenberg. 1995. Induction of tumor reactive CTL from peripheral blood and tumor infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 154: 2257.
4. Vitiello, A., G, Ishioka, H. M. Grey, R. Rose, P. Farness, R. LaFond, L. Yuan, F. V. Chisari, J. Furze, R. Bartholomeuz, et al. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 95:341.
5. Cormier, J. N., M. L. Salgaller, T. Prevette, K. C. Barracchini, L. Rivoltini, N. P. Restifo, S. A. Rosenberg, and F. M. Marincola. 1997. Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A [see comments]. Cancer J. Sci. Am. 3:37.
6. Salgaller, M. L., F. M. Marincola, J. N. Cormier, and S. A. Rosenberg, 1996. Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides. Cancer Res. 56:4749.
7. Rosenberg, S. A., J. C. Yang, D. Schwartzentruber, P. Hwu, F. M. Marincola, S. L. Topalian, N. P. Restifo, E. Dufour. L. Schwartzberg, P. Spiess, et al. 1998. Immunologic and therapeutic evaluation of a synthetic tumor associated peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4:321.
8. Matzinger, P. 1998. An innate sense of danger. Semin, Immunol. 10:399.
9. Marincola, F. M., Jalfe, E. M., Hicklin, D. J., and Ferrone, S. 1999. Escape of human solid tumors from T cell recognition: molecular mechanisms and functional significance. Adv. Immunol. 74, In press.
10. Pockaj, B. A., R. M. Sherry, J. P. Wei, J. R. Yannelli, C. S. Carter, S. F. Leitman, J. A. Carasquillo, S. M. Steinberg, S. A. Rosenberg, and J. C. Yang. 1994. Localization of 111 indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy: augmentation with cyclophosphamide and correlation with response. Cancer 73:1731.
11. Pandolfi, F., L. A. Boyle, L. Trentin, J. T. Kurnick, K. J. Isselbacher, and S. Gattoni-Celli. 1991. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition. Cancer Res. 51:3164.
12. Lengauer, C., K. W. Kinzler. and B. Vogelstein. 1998. Genetic instabilities in human cancers. Nature 396:643.
13. Cormier, J. N., Y. M. Hijazi, A. Abati, P. Fetsch, M. Bettinotti, S. M. Steinberg, S. A. Rosenberg, and F. M. Marincola. 1998. Heterogeneous expression of melanoma-associated antigens (MAA) and HLA-A2 in metastatic melanoma in vivo. Int. J. Cancer 75:517.
14. Romero, P., P. R. Dunhar, D. Valmori, M. Pittet, G. S. Ogg, D. Rimoldi, J. L. Chen, D. Lienard, J. C. Cerottini, and V. Cerundolo. 1998. Ex vivo staining of metastatic lymph nodes by class 1 major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188:1641.
15. Ferrone, S., and F. M. Marincola. 1995. Loss of HLA class 1 antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance, Immunol. Today 16:487.
16. Marincola, F. M., Y. M. Hijazi, P. Felsch, M. L. Salgaller, L. Rivoltini, J. N. Cormier, T. B. Simonis, P. H. Duray, M. Herlyn, Y. Kawakami, and S. A. Rosenberg. 1996. Analysis of expression of the melanoma associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. J. Immunother. 19:192.
17. Lee, K.-H., M. C. Panelli, C. J. Kim, A. Riker, M. Roden, P. A. Fetsch, A. Abati, M. P. Bettinotti, S. A. Rosenberg, and F. M. Marincola. 1998. Functional dissociation between local and systemic immune response following peptide vaccination, J. Immunol. 161:4183.
18. Lehmann, F., M. Marchand, P. Hainaut, P. Pouillart, X. Sastre, H. Ikeda, T. Boon, and P.G. Coulie. 1995. Differences in the antligens recognized by cytolylic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25:340.
19. Maeurer, M. J., S. M. Gollin, D. Martin, W. Swaney, J. Bryant, C. Castelli, P. Robbins, G. Parmiani, W. J. Storkus, and M. T. Lotze. 1996. Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. J. Clin. Invest. 98:1633.
20. Ikeda, H., B. Lethe, F. Lehmann, N. van Baren, J. F. Baurain, C. De Smet, H. Chamnost, M. Vitale, A. Moretta, T. Boon, and P. G. Coulie. 1997. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6:199.
21. + cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo. Int. J. Cancer 66:470.
22. Scheibenbogen, C., I. Weyers, D. Ruiler. M. Willhauck, A. Bittinger, and U. Keilholz. 1996, Expression of gp100 in melanoma metastases resected before or after treatment with IFN a and IL-2. J. Immunother. 19:375.
23. Riker, A., U. S. Kammula, M. C. Panelli, E. Wang, A. Abati, P. Fetsch, K.-H. Lee, S. M. Steinberg, S. A. Rosenberg, and F. M. Marincola. 1999. Immune selection following antigen specific immunotherapy of melanoma. Surgery 126: 112.
24. Nisticò, P., M. Mottolese, C. Mammi, M. Benevolo, D. DelBello, O. Rublu, F. P. Gentile, C. Botti, I. Ventura, and P.G. Natali. 1997. Low frequency of ErbB-2 proto-oncogene overexpression in human leukocyte antigen A2 positive breast cancer patients. J. Natl. Cancer Inst. 89:319.
25. Rivoltini, L., K. C. Baracchini. V. Viggiano, Y. Kawakami, A. Smith, A. Mixon, N. P. Restifo, S. L. Topalian, T. B. Simonis, S.A. Rosenberg, and F. M. Marincola. 1995. Quantitative correlation between HLA class 1 allele expression and recognition of melanoma cells by antigen specific cytoloxic T lymphocytes. Cancer Res. 55:3149.
26. Cormier, J. N., M. C. Panelli, J. A. Hackett, M. Bettinotti, A. Mixon, J. Wunderlich, L. Parker, N. P. Restifo, S. Ferrone, and F. M. Marincola. 1999. Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model. Int. J. Cancer 80:781.
27. Wei, M. L., and P. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides [see comments]. Nature 356:443.
28. Bunce, M., C. M. O'Neill, M. C. Barnardo, P. Krausa, M. J. Browning, P. J. Morris, and K. I. Welsh. 1995. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46:355.
29. Krausa, P., M. Brywka, D. Savage, K. M. Hui, M. Bunce, J. L. Ngai, D. L. Teo, Y. W. Ong, D. Barouch, C. E. Allsop, et al. 1995. Genetic polymorphism within HLA-A *02: significant allelic variation revealed in different populations. Tissue Antigens 45:223.
30. Bettinotti, M., Y. Mitsuichi, K. Bibee, M. Lau, and P. I. Terasaki. 1997. Comprehensive method for the typing of HLA-A B and C alleles by direct sequencing of PCR products obtained from genomic DNA. J. Immunother. 20:425.
31. Brodsky, F. M., and P. Parham. 1982. Monomorphic anti-HLA-A, B, C monoclonal antibodies detecting molecular submits and combinatorial determinants. J. Immunol. 128:129.
32. Tsujisaki, M., K. Sakaguchi, M. Igarashi, P. Richiardi, F. Perosa, and S. Ferrone. 1988. Fine specificity and idiotype diversity of the murine anti-HLA- A2, A28 monoclonal antibodies CR11-351 and KSI. Transplantation 45:632.
33. Kawakami, Y., J. K. Battles, T. Kobayashi, W. Ennis, X. Wang, J. P. Tupesis, F. M. Marincola, P. F. Robbins, V. J. Hearing, M. A. Gonda, and S. A. Rosenberg. 1997. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1. J. lmmunol. Methods 202:13.
34. Altman, J. D., P. H. Moss, P. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes [published erratum appears in 1998, Science 280:1821]. Science 274:94.
35. Pellegrino, M. A., P. G. Natali, A. K. Ng, K. Imai, A. Russo, A. Bigotti, P. Wolf, and S. Ferrone. 1982. Unorthodox expression of IA-like antigens on human tumor cells of nonlymphoid origin: immunological properties, structural profile an clinical relevance. In Immunologic Analysis: Recent Progress in Diagnostic Laboratory Immunology. 1 st Ed. R. M. Nakamura, W. R. Dito, and E. S. Tucker, eds. Mason, New York, p. 159.
36. Marincola, F. M., L. Rivoltini, M. L. Salgaller, M. Player, and S. A. Rosenberg. 1996. Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: evidence for in vivo priming by tumor cells. J. Immunother. 19:266.
37. Engzell, U., P. A. Jakobsson, A. Sigurdson, and J. Zajicek. 1971. Aspiration biopsy of metastatic carcinoma in lymph nodes of the neck: a review of 1101 consecutive cases. Acta Otolaryngol. (Stockh.) 72:138.
38. Perry, M. D., H. F. Seigler. and W. W. Johnston. 1986. Diagnosis of metastatic malignant melanoma by fine needle aspiration biopsy: a clinical and pathologic correlation of 298 cases. J. Natl. Cancer Inst. 77:1013.
39. Behm, F. G., G. J. O'Dowd, and W. J. Frable. 1984. Fine-needle aspiration effects on benign lymph node histology. Am. J. Clin. Pathol 82:195.
40. D'Souza, S., D. Rimoldi, D. Lienard, F. Lejeune, J. C. Cerottini, and P. Romero. 1998. Circulating Melan-A/Mart-1 specific cytolytic T lymphocyte precursors in HLA-A2+ melanoma patients have a memory phenotype. Int. J. Cancer 78:699.
41. Kawakami, Y., S. Eliyahu, C. H. Delgado, P F. Robbins, L. Rivoltini, S. L. Topalian, T. Miki, and S. A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91:3515.
42. Kawakami, Y., S. Eliyahu, C. H. Delgado, P. F. Robbins, K. Sakaguchi, E. Appella, J. R. Yannelli, G. J. Adema, T. Miki. and S. A. Rosenberg. 1994. Identification of a human melanoma antigen recognized by tumor- infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91:6458.
43. Bonner, R. F., M. Emmert-Buck, K. Cole, T. Pohida, R. Chuaqui, S. Goldstein, and L. A. Liotta. 1997. Laser capture microdissection: molecular analysis of tissue. Science 278:1481, 1483.
44. Peterson, L. A., M. R. Brown, A. J. Carlisle, E. C. Kohn. L. A. Liotta, M. R. Emmert-Buck. and D. B. Krizman. 1998. An improved method for construction of directionally cloned cDNA libraries from microdissected cells. Cancer Res. 58:5326.
45. Kruse, N., M. Pette, K. Toyka, and P. Rieckmann. 1997. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. J. Immunol. Methods 210:195.
46. Kern. F., I. P. Surel, C. Brock, B. Freistedt, H. Radtke, A. Scheffold, R. Blasczyk, P. Reinke, J. Schneider-Mergener, A. Radbruch, P. Waiden, and H. D. Volk. 1998. T-cell epilope mapping by flow cytometry. Nat. Med. 4:975.
47. Duggan, D. J., M. Bittner, Y. Chen, P. Meltzer, and J. M. Trent. 1999. Expression profiling using cDNA microarrays. Nat. Genet. 21:10.
48. Yee, C., P.A. Savage, P. P. Lee, M. M. Davis, and P. D. Greenberg. 1999. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J. Immunol. 162:2227.